Myocardial fibrosis, the expansion of the cardiac interstitium through deposition of
extracellular matrix proteins, is a common pathophysiologic companion of many different …

Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left
ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle …

Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …

For both the atria and ventricles, fibrosis is generally recognized as one of the key
determinants of conduction disturbances. By definition, fibrosis refers to an increased …

医学影像人工智能技术的研究与进展, 将极大促进现代心脏瓣膜病介入诊疗的进步. 超声心动图,
心脏磁共振, CT 与心血管造影等成像技术, 在心脏瓣膜病介入治疗术前患者精准筛选 …

Cardiovascular magnetic resonance has been utilized in the management and care of
pediatric patients for nearly 40 years. It has evolved to become an invaluable tool in the …

Rationale: Hypertrophic cardiomyopathy (HCM) is a genetic paradigm of cardiac
hypertrophy. Cardiac hypertrophy and interstitial fibrosis are important risk factors for sudden …

Background Hypertrophic cardiomyopathy (HCM) is the commonest genetic cardiomyopathy
and may result in sudden cardiac death (SCD). Clinical risk stratification scores are utilised …

Non-ischemic cardiomyopathies represent a heterogeneous group of myocardial diseases
potentially leading to heart failure, life-threatening arrhythmias, and eventually death …

Myocardial T1-mapping has become feasible over the past decade as emerging
technological magnetic resonance imaging advances enable increasingly rapid and reliable …